Customised, Individualised Treatment of Metastatic Non-Small-Cell Lung Carcinoma (NSCLC)

A series of phase II and randomised phase III trials in Asia and Europe have confirmed recently that advanced stage non-small-cell lung carcinoma patients with adenocarcinoma subtypes harbouring specific mutations when subjected to targeted therapy experience equivalent survival outcomes as those tr...

Full description

Bibliographic Details
Main Authors: Muhammad Furrukh, Mansour Al-Moundhri, Khawaja F. Zahid, Shiyam Kumar, Ikram Burney
Format: Article
Language:English
Published: Sultan Qaboos University 2013-05-01
Series:Sultan Qaboos University Medical Journal
Subjects:
Online Access:https://journals.squ.edu.om/index.php/squmj/article/view/1750